Ads
related to: Acute Myeloid Leukemia and Bluebird Bio- Info On Myelofibrosis
Learn About Myelofibrosis By
Viewing The Patient Site For More.
- View Myelofibrosis Info
Visit The Official Patient Site To
Learn About A Treatment Option.
- Know The Side Effects
Explore The Risks And Side Effects
Of MF Treatment Option Today.
- Discover Ways To Save
Review Resources & Savings Options
For Treatment On The Patient Site.
- Info On Myelofibrosis
Search results
Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock?
Motley Fool via Yahoo Finance· 4 months agoDespite the Food and Drug Administration (FDA) approving its sickle cell disease (SCD) gene therapy...
2seventy bio (TSVT) to Cut Jobs & Expand JW Therapeutics Deal
Zacks via Yahoo Finance· 7 months ago2seventy bio (TSVT) undertakes a restructuring program and announces plans to reduce 40% of its...
FDA Sounds Positive On Bluebird's One Gene Therapy But Doubts Another
Benzinga via Yahoo Finance· 2 years agoThe FDA signaled in briefing documents released that it may approve Bluebird bio Inc's (NASDAQ:...
Regeneron to acquire 2seventy’s cell therapy pipeline
BioPharma Dive via Yahoo Finance· 3 months agoAbout 150 of the smaller company's employees will also transition to Regeneron, which is setting up...
US FDA approves two gene therapies for sickle cell disease
Reuters via Yahoo News· 4 months ago(Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for...
Is Beam Therapeutics Stock a Buy Now?
Motley Fool· 5 months agoWhen it comes to gene-editing companies on the cutting edge, Beam Therapeutics (NASDAQ: BEAM) is keen to be one of the leaders. While it's a bit of a...
FDA approves first use of CRISPR gene editing to treat sickle cell disease
The Hill via Yahoo News· 4 months agoThe Food and Drug Administration (FDA) on Friday approved a new therapy for treating sickle cell...
Goldman Sachs Sees These 2 ‘Strong Buy’ Stocks Skyrocketing Over 70%
TipRanks via Yahoo Finance· 2 years agoJust when it looked like time to throw in the towel, the market pulled through and delivered a win....
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
Motley Fool· 6 months agoBiotech stocks, especially those that don't have a medicine on the market yet, tend to be among the...
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
Motley Fool· 7 months agoOf course, it's complicated to figure out which are going to soar and which will languish, so it...
Ads
related to: Acute Myeloid Leukemia and Bluebird Bio
